| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | | Total Revenue | 163,716 | 78,782 | 129,593 | 457,075 | | Cost of Revenue | 89,614 | 141,006 |
-
| 387,436 | | | Gross Profit | 74,102 | (62,224) | 129,593 | 69,639 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,930 | (67,754) | 87,070 | 19,908 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 15,388 | 4,906 | 6,612 | 21,069 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 44,784 | 624 | 35,911 | 28,662 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7 | 8 | 30 | 98 | | Earnings Before Interest And Taxes | 44,791 | 632 | 35,941 | 28,760 | | Interest Expense | 5,102 | 4,880 | 4,834 | 8,106 | | Income Before Tax | 39,689 | (4,248) | 31,107 | 20,654 | | Income Tax Expense | (6,333) | (7,940) | 2,336 | (5,061) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 46,022 | 3,692 | 28,771 | 25,715 | | | Non-recurring Events | | Discontinued Operations | (183) | 74 | (3,951) | (465) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 45,839 | 3,766 | 24,820 | 25,250 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $45,839 | $3,766 | $24,820 | $25,250 |
|
0.02% Nasdaq 
Income Statement
